Abstract:Renal function and continence of urine are critically dependent on the proper function of the urinary bladder, which stores urine at low pressure and expels it with a precisely orchestrated contraction. A number of congenital and acquired urological anomalies including posterior urethral valves, benign prostatic hyperplasia, and neurogenic bladder secondary to spina bifida/spinal cord injury can result in pathologic tissue remodeling leading to impaired compliance and reduced capacity(1). Functional or anatomical obstruction of the urinary tract is frequently associated with these conditions, and can lead to urinary incontinence and kidney damage from increased storage and voiding pressures(2). Surgical implantation of gastrointestinal segments to expand organ capacity and reduce intravesical pressures represents the primary surgical treatment option for these disorders when medical management fails(3). However, this approach is hampered by the limitation of available donor tissue, and is associated with significant complications including chronic urinary tract infection, metabolic perturbation, urinary stone formation, and secondary malignancy(4,5). Current research in bladder tissue engineering is heavily focused on identifying biomaterial configurations which can support regeneration of tissues at defect sites. Conventional 3-D scaffolds derived from natural and synthetic polymers such as small intestinal submucosa and poly-glycolic acid have shown some short-term success in supporting urothelial and smooth muscle regeneration as well as facilitating increased organ storage capacity in both animal models and in the clinic(6,7). However, deficiencies in scaffold mechanical integrity and biocompatibility often result in deleterious fibrosis(8), graft contracture(9), and calcification(10), thus increasing the risk of implant failure and need for secondary surgical procedures. In addition, restoration of normal voiding characteristics utilizing standard biomaterial constructs for augmentation cystoplasty has yet to be achieved, and therefore research and development of novel matrices which can fulfill this role is needed. In order to successfully develop and evaluate optimal biomaterials for clinical bladder augmentation, efficacy research must first be performed in standardized animal models using detailed surgical methods and functional outcome assessments. We have previously reported the use of a bladder augmentation model in mice to determine the potential of silk fibroin-based scaffolds to mediate tissue regeneration and functional voiding characteristics.(11,12) Cystometric analyses of this model have shown that variations in structural and mechanical implant properties can influence the resulting urodynamic features of the tissue engineered bladders(11,12). Positive correlations between the degree of matrix-mediated tissue regeneration determined histologically and functional compliance and capacity evaluated by cystometry were demonstrated in this model(11,12). These results therefore suggest that functional evaluations of biomaterial configurations in rodent bladder augmentation systems may be a useful format for assessing scaffold properties and establishing in vivo feasibility prior to large animal studies and clinical deployment. In the current study, we will present various surgical stages of bladder augmentation in both mice and rats using silk scaffolds and demonstrate techniques for awake and anesthetized cystometry.

Injectable biomaterials for incontinence and vesico-ureteral reflux: current status and future promise

Injectable, porous, biohybrid hydrogels incorporating decellularized tissue components for soft tissue applications.

Biodegradable and bioactive nHAC/CMs/PLLA scaffolds for bone tissue engineering

Regenerative medicine and injection therapies in stress urinary incontinence

Use of bioactive extracellular matrix fragments as a urethral bulking agent to treat stress urinary incontinence

Biodegradable ring-shaped implantable device for intravesical therapy of bladder disorders

Detachable self-sealing membrane system for the endoscopic treatment of incontinence

Research progress of biomaterials and innovative technologies in urinary tissue engineering

A Biomimetic Mesh for Treating Female Stress Urinary Incontinence

BIODEGRADABLE, THERMALLY RESPONSIVE HYDROGELS FOR MYOCARDIAL INFARCTION TREATMENT

Application of Biomaterials and Tissue Engineering in Bladder Regeneration

Injectable, stretchable, toughened, bioadhesive composite hydrogel for bladder injury repair

Tissue engineered bulking agent with adipose-derived stem cells and silk fibroin microspheres for the treatment of intrinsic urethral sphincter deficiency

Particulate Versus Non-Particulate Bulking Agents In The Treatment Of Stress Urinary Incontinence

Injectable biomaterials for translational medicine

Where are we in 2024 in the development of materials for surgical treatment of pelvic organ prolapse and stress urinary incontinence?

Microfluidic-Generated Injectable Bulking Agents with Biocompatible Surfaces and Their Mid-term Outcomes in a Rat Model with Anal Sphincter Injury

Injectable Functional Biomaterials for Minimally Invasive Surgery

Evaluation of biomaterials for bladder augmentation using cystometric analyses in various rodent models

Applicability of regenerative medicine and tissue engineering for the treatment of stress urinary incontinence in female patients

Emerging Bioactive Agent Delivery-Based Regenerative Therapies for Lower Genitourinary Tissues